Carvajal Alejandra has filed 35 insider transactions across 1 company since January 2024.
Most recent transaction: a disposition of 1800 shares of Mersana Therapeutics, Inc. ($MRSN) on January 06, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 1800 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.04% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 4500 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.09% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 6702 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.13% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 3047 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.06% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | U | Common Stock | 3131 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.06% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Restricted Stock Units | 2166 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.04% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Restricted Stock Units | 1500 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.03% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Restricted Stock Units | 717 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Restricted Stock Units | 100 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.00% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 7921 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.16% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 1078 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.02% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 4922 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.10% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | D | Stock Option (right to buy) | 1527 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.03% |
| Jan. 15, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Common Stock | 12500 | $0.00 | 83,392.0000 | 0 | 17.63% | 0.00% |
| Jan. 16, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | S | Common Stock | 5096 | $0.58 | 78,296.0000 | 0 | 6.11% | 0.00% |
| Jan. 15, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Restricted Stock Unit | 12500 | $0.00 | 37,500.0000 | 0 | 25.00% | 0.00% |
| Jan. 15, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | A | Stock Option (Right to Buy) | 243750 | $0.00 | 243,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 15, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | A | Restricted Stock Unit | 54167 | $0.00 | 54,167.0000 | 0 | 9999.99% | 0.00% |
| Jan. 14, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Common Stock | 2500 | $0.00 | 71,844.0000 | 0 | 3.61% | 0.00% |
| Jan. 15, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | S | Common Stock | 952 | $0.63 | 70,892.0000 | 0 | 1.33% | 0.00% |
| Jan. 14, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Restricted Stock Unit | 2500 | $0.00 | 2,500.0000 | 0 | 50.00% | 0.00% |
| Jan. 13, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Restricted Stock Unit | 8958 | $0.00 | 17,917.0000 | 0 | 33.33% | 0.00% |
| Jan. 13, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Common Stock | 8958 | $0.00 | 72,674.0000 | 0 | 14.06% | 0.00% |
| Jan. 14, 2025 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | S | Common Stock | 3330 | $0.66 | 69,344.0000 | 0 | 4.58% | 0.00% |
| Oct. 3, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | S | Common Stock | 5598 | $1.96 | 63,716.0000 | 0 | 8.08% | 0.00% |
| Oct. 1, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Restricted Stock Unit | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 2, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | S | Common Stock | 8089 | $2.00 | 69,314.0000 | 0 | 10.45% | 0.00% |
| Oct. 1, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Common Stock | 50000 | $0.00 | 77,403.0000 | 0 | 182.46% | 0.00% |
| Jan. 14, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Restricted Stock Unit | 2500 | $0.00 | 5,000.0000 | 0 | 33.33% | 0.00% |
| Jan. 13, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Common Stock | 8958 | $0.00 | 29,284.0000 | 0 | 44.07% | 0.00% |
| Jan. 14, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Common Stock | 2500 | $0.00 | 31,784.0000 | 0 | 8.54% | 0.00% |
| Jan. 16, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | S | Common Stock | 4381 | $2.71 | 27,403.0000 | 0 | 13.78% | 0.00% |
| Jan. 15, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | A | Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 13, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | M | Restricted Stock Unit | 8958 | $0.00 | 26,875.0000 | 0 | 25.00% | 0.00% |
| Jan. 15, 2024 | Mersana Therapeutics, Inc. | $MRSN | Carvajal Alejandra | SVP, Chief Legal Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |